Los Angeles Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Sell |
8,037
-36,570
| -82% | -$1.01M | ﹤0.01% | 1155 |
|
|
2025
Q1 | $991K | Sell |
44,607
-10,921
| -20% | -$243K | ﹤0.01% | 567 |
|
|
2024
Q4 | $1.1M | Sell |
55,528
-44,473
| -44% | -$880K | ﹤0.01% | 588 |
|
|
2024
Q3 | $2.5M | Buy |
100,001
+20,801
| +26% | +$520K | 0.01% | 416 |
|
|
2024
Q2 | $1.48M | Sell |
79,200
-60,650
| -43% | -$1.13M | 0.01% | 524 |
|
|
2024
Q1 | $2.76M | Sell |
139,850
-7,332
| -5% | -$145K | 0.01% | 427 |
|
|
2023
Q4 | $2.58M | Buy |
147,182
+1,540
| +1% | +$27K | 0.01% | 427 |
|
|
2023
Q3 | $2.53M | Sell |
145,642
-14,752
| -9% | -$256K | 0.01% | 400 |
|
|
2023
Q2 | $2.26M | Buy |
160,394
+46,747
| +41% | +$658K | 0.01% | 465 |
|
|
2023
Q1 | $1.22M | Sell |
113,647
-4,059
| -3% | -$43.7K | 0.01% | 609 |
|
|
2022
Q4 | $1.76M | Sell |
117,706
-5,284
| -4% | -$79.2K | 0.01% | 548 |
|
|
2022
Q3 | $1.58M | Buy |
122,990
+57,408
| +88% | +$737K | 0.01% | 566 |
|
|
2022
Q2 | $635K | Buy |
65,582
+260
| +0.4% | +$2.52K | ﹤0.01% | 878 |
|
|
2022
Q1 | $649K | Buy |
65,322
+5,352
| +9% | +$53.2K | ﹤0.01% | 926 |
|
|
2021
Q4 | $706K | Buy |
59,970
+27,886
| +87% | +$328K | ﹤0.01% | 854 |
|
|
2021
Q3 | $365K | Sell |
32,084
-13,692
| -30% | -$156K | ﹤0.01% | 1213 |
|
|
2021
Q2 | $638K | Buy |
45,776
+23,463
| +105% | +$327K | ﹤0.01% | 1061 |
|
|
2021
Q1 | $413K | Sell |
22,313
-5,810
| -21% | -$108K | ﹤0.01% | 1302 |
|
|
2020
Q4 | $497K | Buy |
28,123
+1,591
| +6% | +$28.1K | ﹤0.01% | 1210 |
|
|
2020
Q3 | $406K | Buy |
26,532
+4,179
| +19% | +$63.9K | ﹤0.01% | 1167 |
|
|
2020
Q2 | $570K | Buy |
22,353
+4,413
| +25% | +$113K | ﹤0.01% | 1061 |
|
|
2020
Q1 | $278K | Buy |
17,940
+4,900
| +38% | +$75.9K | ﹤0.01% | 1078 |
|
|
2019
Q4 | $144K | Buy |
+13,040
| New | +$144K | ﹤0.01% | 1222 |
|